Today: 20 May 2026
Singapore Airlines stock in focus: supply-chain “new norm” and Feb 24 update loom
8 February 2026
2 mins read

Singapore Airlines stock in focus: supply-chain “new norm” and Feb 24 update loom

Singapore, Feb 8, 2026, 15:20 SGT — Closed for the session.

  • Singapore Airlines ended Friday at S$6.70, slipping 0.15%.
  • Investors are watching supply-chain bottlenecks again, with concerns raised at the Singapore Airshow now echoing in airline cost projections.
  • Singapore Airlines is up next, with its third-quarter FY2025/26 business update slated for Feb 24, right after the market closes.

Shares of Singapore Airlines Ltd (SGX: C6L) closed at S$6.70 on Friday, slipping 0.15% before the weekend. Trading volume hit about 8.94 million shares, fluctuating between S$6.62 and S$6.71 during the session. Over the last 52 weeks, the stock’s range has been S$5.90 to S$7.63.

It wasn’t a big shift, but the argument hasn’t cooled off. Investors are wrestling with how tough it’s going to be for airlines to ramp up capacity with engine and parts delays still dragging on—and with “extra insurance” through spares and leases now coming at a higher price.

This is coming right as the Singapore Airshow finishes up on Sunday, with markets set to reopen Monday, Feb. 9. There’s still a shot at more headlines from both suppliers and carriers. When it comes to airline stocks, cost chatter can shake things up just as much as any demand story.

ST Engineering’s Jeffrey Lam warned at the airshow that persistent delivery and maintenance bottlenecks could well become “the new norm” for the industry, citing ongoing delays from both Airbus and Boeing, plus congested engine shops. Scoot CEO Leslie Thng said the airline had to “secure more spare engines at our own expense.” IATA boss Willie Walsh described the ongoing squeeze as “very frustrating” for carriers. According to IATA, global passenger traffic in 2025 ended up about 9.3% higher than 2019, with another 4.9% growth expected this year. The group also pegged extra costs from airlines operating older jets longer at $11 billion in 2025. Reuters

Aircraft uptime is critical for Singapore Airlines, which operates its flagship premium flights alongside the budget Scoot arm, and the impact lands right on margins. Persistent bottlenecks force carriers into leasing agreements, ramped-up maintenance, and stockpiling spare engines just to keep flights running on time.

Changi Exhibition Centre is playing host to major names in aviation and defence, as organisers tout the airshow as a display of the industry’s “latest and the greatest.” The showcase kicked off Feb. 3 and wraps up Feb. 8. AP News

Singapore Airlines runs both its flagship full-service brand and the budget-friendly Scoot, along with a unit handling engineering services. Shares trade in Singapore with the ticker C6L.

Fuel is in focus, too. Jet fuel tends to move with crude, so even a small uptick in oil prices threatens to chip away at profits from packed flights — measured by the load factor, or percentage of seats sold — and the effect’s especially pronounced on longer international routes.

The risks are hard to ignore. Persistent delivery delays and ongoing parts shortages through the northern summer peak could force airlines to shell out higher leasing and maintenance costs right when they’d rather not. If demand sags, yields — that’s revenue per passenger kilometre — would take a hit.

Singapore Airlines gives investors a liquid angle on the Singapore travel theme, with shares often reacting to shifts in risk appetite—not just airline-specific headlines.

Singapore Airlines will deliver its FY2025/26 third-quarter business update after markets close on Feb. 24, according to a filing on the Singapore Exchange.

Stock Market Today

  • AMD Stock Rises Amid AI Chip Export Speculation and Momentum Trade
    May 20, 2026, 10:09 AM EDT. Advanced Micro Devices (NASDAQ:AMD) gained 2.48% in premarket trading to $424.30, buoyed by positive momentum in growth stocks and hopes of relaxed U.S. AI chip export restrictions to China. AMD trades well above key moving averages, signaling a strong uptrend, although momentum indicators like MACD suggest cooling upside pressure. Analysts maintain a bullish outlook, with average price targets near $447 and recent upgrades from Evercore ISI and Daiwa Capital lifting forecasts up to $579 and $500 respectively. Key resistance stands at $469, near AMD's 52-week high. Heavy ETF exposure could amplify stock moves amid fund flows, making AMD a closely watched semiconductor play amid evolving geopolitical and market conditions.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next
Previous Story

Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop